Last update 01 Nov 2024

Delpazolid

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
DPZ
+ [2]
Mechanism
50S subunit inhibitors(50S ribosomal subunit inhibitors), Protein biosynthesis inhibitors
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
RegulationOrphan Drug (EU)
Login to view timeline

Structure

Molecular FormulaC14H17FN4O3
InChIKeyQLUWQAFDTNAYPN-LLVKDONJSA-N
CAS Registry1219707-39-7

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Mycobacterium Abscessus InfectionPhase 2
KR
16 Jan 2024
Community Acquired PneumoniaPhase 1
CN
30 Jan 2022
TuberculosisPhase 1
CN
09 May 2019
Soft Tissue InfectionsPhase 1
CN
-
Bacteremia due to Methicillin resistant Staphylococcus aureusPreclinical
KR
26 Apr 2022
Pulmonary TuberculosisDiscovery
KR
10 Dec 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
76
Bedaquiline, Delamanid, Moxifloxacin
(Arm1(D0))
(zopiwesbef) = bkfazghkix opfbqypejt (ztkmrijttl, sonrbhgqem - jznemjkoeb)
-
28 Oct 2024
Delpazolid+Bedaquiline, Delamanid, Moxifloxacin
(Arm2(D400))
(zopiwesbef) = snnokxhilv opfbqypejt (ztkmrijttl, tzpbsubgxb - kastsveznk)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free